EP3579837
AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.2.2018EP published:
7.6.2023EP application number:
18751042.5
EPO information:
European Patent Register
Max expiry date:
11.2.2038
Title in English:
AXITINIB, NINTEDANIB OR LENVATINIB FOR THE TREATMENT OF ROSACEA AND ATOPIC DERMATITISLanguage of the patent:
English
Timeline
Today
12.2.2018EP application
7.6.2023EP Publication
Owner
Name:
AiViva Biopharma, Inc.Address:
848 North Rainbow Boulevard, Suite 2654, Las Vegas, NV 89107, US
Inventor
Name:
TANG-LIU, DianeAddress:
Las Vegas, NV 89107, US
Name:
DEVRIES, Gerald, WoodrowAddress:
San Clemente, CA 92673, US
Priority
Number:
201762457929 PDate:
12.2.2017Country:
US
Classification
Categories:
A61K 31/4439, A61K 31/496, A61K 31/47, A61P 17/00, A61P 17/02, A61P 17/06, A61K 9/00